Warning: The NCBI web site requires JavaScript to function. more...
Generate a file for use with external citation management software.
Intensity-modulated radiotherapy in head and neck cancer: results of the prospective study GORTEC 2004-03.
Toledano I, Graff P, Serre A, Boisselier P, Bensadoun RJ, Ortholan C, Pommier P, Racadot S, Calais G, Alfonsi M, Favrel V, Giraud P, Lapeyre M.
Radiother Oncol. 2012 Apr;103(1):57-62. Epub 2012 Jan 31.
Related citations
Dose-response analysis of acute oral mucositis and pharyngeal dysphagia in patients receiving induction chemotherapy followed by concomitant chemo-IMRT for head and neck cancer.
Bhide SA, Gulliford S, Schick U, Miah A, Zaidi S, Newbold K, Nutting CM, Harrington KJ.
Radiother Oncol. 2012 Apr;103(1):88-91. Epub 2012 Jan 24.
Late toxicities after conventional radiation therapy alone for nasopharyngeal carcinoma.
Tuan JK, Ha TC, Ong WS, Siow TR, Tham IW, Yap SP, Tan TW, Chua ET, Fong KW, Wee JT.
Radiother Oncol. 2012 Jan 24. [Epub ahead of print]
Volumetric modulated arc therapy for nasopharyngeal carcinoma: A dosimetric comparison with TomoTherapy and step-and-shoot IMRT.
Lu SH, Cheng JC, Kuo SH, Lee JJ, Chen LH, Wu JK, Chen YH, Chen WY, Wen SY, Chong FC, Wu CJ, Wang CW.
Radiother Oncol. 2012 Jan 9. [Epub ahead of print]
Accuracy of self-reported tobacco assessments in a head and neck cancer treatment population.
Warren GW, Arnold SM, Valentino JP, Gal TJ, Hyland AJ, Singh AK, Rangnekar VM, Cummings KM, Marshall JR, Kudrimoti MR.
Radiother Oncol. 2012 Apr;103(1):45-8. Epub 2011 Nov 25.
The seventh edition of the UICC/AJCC staging system for nasopharyngeal carcinoma is prognostically useful for patients treated with intensity-modulated radiotherapy from an endemic area in China.
Chen L, Mao YP, Xie FY, Liu LZ, Sun Y, Tian L, Tang LL, Lin AH, Li L, Ma J.
Radiother Oncol. 2011 Nov 19. [Epub ahead of print]
Multicenter phase II study of an opioid-based pain control program for head and neck cancer patients receiving chemoradiotherapy.
Zenda S, Matsuura K, Tachibana H, Homma A, Kirita T, Monden N, Iwae S, Ota Y, Akimoto T, Otsuru H, Tahara M, Kato K, Asai M.
Radiother Oncol. 2011 Dec;101(3):410-4. Epub 2011 Oct 14.
A comparison of several modulated radiotherapy techniques for head and neck cancer and dosimetric validation of VMAT.
Stieler F, Wolff D, Schmid H, Welzel G, Wenz F, Lohr F.
Radiother Oncol. 2011 Dec;101(3):388-93. Epub 2011 Sep 30.
Feasibility of tomotherapy to reduce normal lung and cardiac toxicity for distal esophageal cancer compared to three-dimensional radiotherapy.
Nguyen NP, Krafft SP, Vinh-Hung V, Vos P, Almeida F, Jang S, Ceizyk M, Desai A, Davis R, Hamilton R, Modarresifar H, Abraham D, Smith-Raymond L.
Radiother Oncol. 2011 Dec;101(3):438-42. Epub 2011 Sep 9.
¹⁸F-FDG-PET imaging in radiotherapy tumor volume delineation in treatment of head and neck cancer.
Delouya G, Igidbashian L, Houle A, Bélair M, Boucher L, Cohade C, Beaulieu S, Filion EJ, Coulombe G, Hinse M, Martel C, Després P, Nguyen-Tan PF.
Radiother Oncol. 2011 Dec;101(3):362-8. Epub 2011 Aug 30.
Hypoxia imaging with [F-18] FMISO-PET in head and neck cancer: potential for guiding intensity modulated radiation therapy in overcoming hypoxia-induced treatment resistance.
Hendrickson K, Phillips M, Smith W, Peterson L, Krohn K, Rajendran J.
Radiother Oncol. 2011 Dec;101(3):369-75. Epub 2011 Aug 27.
Residual setup errors and dose variations with less-than-daily image guided patient setup in external beam radiotherapy for esophageal cancer.
Han C, Schiffner DC, Schultheiss TE, Chen YJ, Liu A, Wong JY.
Radiother Oncol. 2012 Feb;102(2):309-14. Epub 2011 Aug 27.
Gefitinib plus cisplatin and radiotherapy in previously untreated head and neck squamous cell carcinoma: a phase II, randomized, double-blind, placebo-controlled study.
Gregoire V, Hamoir M, Chen C, Kane M, Kawecki A, Julka PK, Wang HM, Prasad S, D'Cruz AK, Radosevic-Jelic L, Kumar RR, Korzeniowski S, Fijuth J, Machiels JP, Sellers MV, Tchakov I, Raben D.
Radiother Oncol. 2011 Jul;100(1):62-9. Epub 2011 Aug 5.
Development and validation of a nomogram for prediction of survival and local control in laryngeal carcinoma patients treated with radiotherapy alone: a cohort study based on 994 patients.
Egelmeer AG, Velazquez ER, de Jong JM, Oberije C, Geussens Y, Nuyts S, Kremer B, Rietveld D, Leemans CR, de Jong MC, Rasch C, Hoebers F, Homer J, Slevin N, West C, Lambin P.
Radiother Oncol. 2011 Jul;100(1):108-15. Epub 2011 Jul 23.
Spatial relationship of phosphorylated epidermal growth factor receptor and activated AKT in head and neck squamous cell carcinoma.
Nijkamp MM, Hoogsteen IJ, Span PN, Takes RP, Lok J, Rijken PF, van der Kogel AJ, Bussink J, Kaanders JH.
Radiother Oncol. 2011 Oct;101(1):165-70. Epub 2011 Jul 19.
Maximum tolerated dose in a phase I trial on adaptive dose painting by numbers for head and neck cancer.
Madani I, Duprez F, Boterberg T, Van de Wiele C, Bonte K, Deron P, De Gersem W, Coghe M, De Neve W.
Radiother Oncol. 2011 Dec;101(3):351-5.
Randomized phase III trial (GORTEC 98-03) comparing re-irradiation plus chemotherapy versus methotrexate in patients with recurrent or a second primary head and neck squamous cell carcinoma, treated with a palliative intent.
Tortochaux J, Tao Y, Tournay E, Lapeyre M, Lesaunier F, Bardet E, Janot F, Lusinchi A, Benhamou E, Bontemps P, Maingon P, Calais G, Daly-Schveitzer N, Verrelle P, Bourhis J.
Radiother Oncol. 2011 Jul;100(1):70-5. Epub 2011 Jul 7.
Accelerated radiotherapy and concomitant high dose chemotherapy in non resectable stage IV locally advanced HNSCC: results of a GORTEC randomized trial.
Bourhis J, Lapeyre M, Tortochaux J, Lusinchi A, Etessami A, Ducourtieux M, Geoffrois L, Domenge C, Verrelle P, Wibault P, Janot F, Temam S, Blanchard P, Tao YG, Auperin A.
Radiother Oncol. 2011 Jul;100(1):56-61. Epub 2011 Aug 8.
Residual DNA double strand breaks in perfused but not in unperfused areas determine different radiosensitivity of tumours.
Menegakis A, Eicheler W, Yaromina A, Thames HD, Krause M, Baumann M.
Radiother Oncol. 2011 Jul;100(1):137-44. Epub 2011 Aug 5.
Comparison of (immuno-)fluorescence data with serial [¹⁸F]Fmiso PET/CT imaging for assessment of chronic and acute hypoxia in head and neck cancers.
Maftei CA, Shi K, Bayer C, Astner ST, Vaupel P.
Radiother Oncol. 2011 Jun;99(3):412-7. Epub 2011 Jun 28.
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on